Gene · 57721
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 1,078
Download this page as JSON| Grant | Title | METTL14 papers | Newest fiscal year |
|---|---|---|---|
| DP2AG055947 | Characterization of DNA N6-methyl adenine and its role in epigenetic memory | 2 | 2021 |
| R01AG057497 | Functional characterization of Alzheimer's disease associated genetic variants | 2 | 2021 |
| R01CA160331 | Chromatin basis of cellular senescence and its implication in epithelial ovarian cancer | 2 | 2021 |
| R01CA163377 | Targeting EZH2 in CARM1-expressing epithelial ovarian cancer | 2 | 2021 |
| R01CA198090 | Integrated Signaling in Pancreatic Cancer Progression | 2 | 2021 |
| R01CA211336 | Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma | 2 | 2021 |
| R01ES027576 | DEVELOPMENTAL TOXICITY OF ORGANOPHOSPHATE-BASED FLAME RETARDANTS | 2 | 2021 |
| R01GM123314 | Mapping RNA protein interaction networks in the human genome | 2 | 2021 |
| R01GM126421 | The Functional Analysis of the Coactivator CARM1 | 2 | 2021 |
| R01HD088626 | Epigenetic Therapy and Prader-Willi Syndrome | 2 | 2021 |
| R01NS099531 | Therapeutic Targeting of an lncRNA in Experimental Stroke Using STAIR Criteria | 2 | 2021 |
| R01NS101960 | Targeting alpha-synuclein after cerebral ischemia as a function of sex and age | 2 | 2021 |
| R01NS103434 | Dual Targeting of Brain Tumor Initiating Cells through Inhibition of BMI1 and EZH2 (R01NS103434) | 2 | 2021 |
| R21ES031510 | m6A Epitranscriptomics in Toxicant Associated Steatohepatitis | 2 | 2021 |
| R35CA197718 | Dynamic Complexity of Brain Tumor Stem Cells (R35CA197718) | 2 | 2021 |
| R35GM133711 | The Molecular and Regulatory Mechanism of m6A mRNA Modification | 2 | 2021 |
| T32GM075762 | Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame | 2 | 2021 |
| U01CA217078 | Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis | 2 | 2021 |
| U19AI131130 | Engineering a human brain organoid-based platform to study neurotropic viruses | 2 | 2021 |
| U54AI150470 | The Center for HIV RNA Studies (CRNA) | 2 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/grants?page=29